Digipath
Home > Boards > US Listed > Medical - Healthcare > Sanofi-Aventis (sny)

A bump on the road but still going!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Trend-Setter Member Profile
 
Followed By 3
Posts 538
Boards Moderated 0
Alias Born 07/19/13
160x600 placeholder
FDA Approves Expanded Use of Adacel® (Tdap) Vaccine for Repeat Vaccination PR Newswire (US) - 1/14/2019 4:47:00 PM
Sanofi, Regeneron Restructure Immuno-Oncology Agreement Dow Jones News - 1/7/2019 3:14:00 AM
Sanofi Investing EUR80 Million in Germany's BioNTech Dow Jones News - 1/4/2019 6:52:00 AM
Sanofi, Merck Get FDA Approval for Vaxelis Dow Jones News - 12/26/2018 4:07:00 PM
Opiant Pharmaceuticals Inks Deal With Sanofi to Develop Cannabinoid Overdose Treatment Dow Jones News - 12/26/2018 9:39:00 AM
Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq Dow Jones News - 12/18/2018 6:38:00 PM
Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq PR Newswire (US) - 12/18/2018 4:30:00 PM
MyoKardia Sees Topline Results from Phase 1b Study of MYK-491 Dow Jones News - 12/11/2018 9:31:00 AM
Euro Health Stocks No Longer Insulated From Global Selloff -- Market Talk Dow Jones News - 12/6/2018 5:25:00 AM
Sanofi to Cut Around 500 Net Jobs in France as It Moves to Restructure Globally Dow Jones News - 12/5/2018 1:02:00 PM
Sanofi Moves to Restructure, Announces Layoffs -AFP Dow Jones News - 12/5/2018 11:50:00 AM
ODYSSEY OUTCOMES investigators highlight at AHA that Praluent® (alirocumab) Injection was associated with fewer deaths from ... PR Newswire (US) - 11/11/2018 8:15:00 AM
New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) Injection cardiovascular out... PR Newswire (US) - 11/7/2018 5:00:00 PM
Regeneron, Sanofi Get FDA Priority Review for Dupixent in Adolescents Dow Jones News - 11/6/2018 11:14:00 AM
Regulus Restructures Collaboration With Sanofi Dow Jones News - 11/6/2018 8:53:00 AM
FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-se... PR Newswire (US) - 11/6/2018 8:00:00 AM
Sanofi expands Insulins VALyou Savings Program, helping more people living with diabetes PR Newswire (US) - 11/1/2018 7:57:00 AM
Sanofi, Denali Enter Collaboration Deal Valued at Up to $1 Billion Dow Jones News - 11/1/2018 2:52:00 AM
Sanofi Q3 2018 Performance Confirms Return to Growth PR Newswire (US) - 10/31/2018 8:00:00 AM
Sanofi Shares Jump After Healthy 3Q -- Update Dow Jones News - 10/31/2018 5:36:00 AM
Sanofi Returned to Growth in 3Q Dow Jones News - 10/31/2018 3:03:00 AM
FDA grants priority review for Sanofi's dengue vaccine candidate PR Newswire (US) - 10/30/2018 5:12:00 PM
Breakthroughs in Breast Cancer Research PR Newswire (US) - 10/23/2018 1:03:00 PM
FDA Approves Asthma Indication for Regeneron and Sanofi's Dupixent Dow Jones News - 10/19/2018 6:52:00 PM
FDA approves asthsma indication for Dupixent® (dupilumab) PR Newswire (US) - 10/19/2018 5:55:00 PM
Trend-Setter   Wednesday, 01/03/18 04:27:02 PM
Re: Trend-Setter post# 79
Post # of 89 
A bump on the road but still going!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist